The Pink Sheet
Stacy Cline Amin spoke to The Pink Sheet about the Biden administration tapping Robert Califf to once again lead the U.S. Food and Drug Administration (FDA).
According to Stacy, bringing an inexperienced commissioner up to speed would be a substantial resource drain at a time when agency staff already are stretched and exhausted from fighting the coronavirus pandemic.
“The prospect of having someone with no experience at the FDA would be daunting to them,” Stacy said.
Read the full article (subscription required).
Disclaimer
Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
